A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea
NCT04589039
·
clinicaltrials.gov ↗
COMPLETED
Status
662
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Neoplasms
Sponsor
Takeda